How to treat the recurrence of colon cancer in pregnant women
summary
My sister is still pregnant. Recently she went to the hospital and was found to have colon cancer. Fortunately, it was early, so she had a resection operation under the doctor's advice. The doctor said that there would be a recurrence of colon cancer after operation. Now let me talk about how to treat the recurrence of colon cancer in pregnant women.
How to treat the recurrence of colon cancer in pregnant women
First: colon cancer recurrence rate as high as 30% - 50%, such a high recurrence rate determines the colon cancer patients must do a good review after surgery. Prevention and health care should also be done well after colon cancer operation. In order to prevent postoperative recurrence and metastasis of colon cancer, patients should be followed up regularly after discharge.
Second: because of the recurrence and metastasis of colon cancer after operation, this is the key to the survival of colon cancer after operation. The residual tumor may not recur in vivo. Therefore, before laparotomy, chemotherapy or enema can prevent the spread of cancer cells, kill and eliminate cancer cells.
Third: for postoperative recurrence of colon cancer, patients should go to the hospital for treatment in time. The treatment is mainly based on radiotherapy and chemotherapy. If the pathological range of metastasis is not large, targeted treatment can also be applied. Patients should pay attention to the combination of radiotherapy and chemotherapy with taking selenium Weikang chewable tablets, so as to improve the side effects of radiotherapy and chemotherapy, improve the patient's physique, and avoid the late recurrence of patients Recurrence occurred again.
matters needing attention
Patients with colon cancer after resection should be particularly alert to postoperative recurrence, because the recurrence rate of colon cancer is very high, so it does not mean that the resection will be OK, but also need further consolidation treatment under the doctor's advice.